Literature DB >> 17965187

Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.

Mari Ikuta1, Maria Kornienko, Noel Byrne, John C Reid, Shinji Mizuarai, Hidehito Kotani, Sanjeev K Munshi.   

Abstract

The p90 ribosomal S6 kinases (RSKs) also known as MAPKAP-Ks are serine/threonine protein kinases that are activated by ERK or PDK1 and act as downstream effectors of mitogen-activated protein kinase (MAPK). RSK1, a member of the RSK family, contains two distinct kinase domains in a single polypeptide chain, the regulatory C-terminal kinase domain (CTKD) and the catalytic N-terminal kinase domain (NTKD). Autophosphorylation of the CTKD leads to activation of the NTKD that subsequently phosphorylates downstream substrates. Here we report the crystal structures of the unactivated RSK1 NTKD bound to different ligands at 2.0 A resolution. The activation loop and helix alphaC, key regulatory elements of kinase function, are disordered. The DFG motif of the inactive RSK1 adopts an "active-like" conformation. The beta-PO(4) group in the AMP-PCP complex adopts a unique conformation that may contribute to inactivity of the enzyme. Structures of RSK1 ligand complexes offer insights into the design of novel anticancer agents and into the regulation of the catalytic activity of RSKs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965187      PMCID: PMC2222827          DOI: 10.1110/ps.073123707

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  45 in total

1.  Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase.

Authors:  J Xing; D D Ginty; M E Greenberg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

2.  IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.

Authors:  G J Schouten; A C Vertegaal; S T Whiteside; A Israël; M Toebes; J C Dorsman; A J van der Eb; A Zantema
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

3.  A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.

Authors:  Shane Atwell; Jason M Adams; John Badger; Michelle D Buchanan; Ingeborg K Feil; Karen J Froning; Xia Gao; Jörg Hendle; Kevin Keegan; Barbara C Leon; Hans J Müller-Dieckmann; Vicki L Nienaber; Brian W Noland; Kai Post; K R Rajashankar; Aurora Ramos; Marijane Russell; Stephen K Burley; Sean G Buchanan
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

4.  Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK.

Authors:  K N Dalby; N Morrice; F B Caudwell; J Avruch; P Cohen
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

5.  Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK.

Authors:  S A Richards; J Fu; A Romanelli; A Shimamura; J Blenis
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

6.  A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.

Authors:  A Palmer; A C Gavin; A R Nebreda
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor.

Authors:  J Zheng; D R Knighton; L F ten Eyck; R Karlsson; N Xuong; S S Taylor; J M Sowadski
Journal:  Biochemistry       Date:  1993-03-09       Impact factor: 3.162

8.  Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2.

Authors:  F Meggio; A Donella Deana; M Ruzzene; A M Brunati; L Cesaro; B Guerra; T Meyer; H Mett; D Fabbro; P Furet
Journal:  Eur J Biochem       Date:  1995-11-15

9.  Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

Authors:  Philippe P Roux; Bryan A Ballif; Rana Anjum; Steven P Gygi; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

10.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

Authors:  N S Gray; L Wodicka; A M Thunnissen; T C Norman; S Kwon; F H Espinoza; D O Morgan; G Barnes; S LeClerc; L Meijer; S H Kim; D J Lockhart; P G Schultz
Journal:  Science       Date:  1998-07-24       Impact factor: 47.728

View more
  18 in total

1.  p90 ribosomal S6 kinase 1 (RSK1) and the catalytic subunit of protein kinase A (PKA) compete for binding the pseudosubstrate region of PKAR1alpha: role in the regulation of PKA and RSK1 activities.

Authors:  Xianlong Gao; Deepti Chaturvedi; Tarun B Patel
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

2.  Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer.

Authors:  Nada Milosevic; Benjamin Kühnemuth; Leonie Mühlberg; Stefanie Ripka; Heidi Griesmann; Carolin Lölkes; Malte Buchholz; Daniela Aust; Christian Pilarsky; Sebastian Krug; Thomas Gress; Patrick Michl
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.

Authors:  Darkhan Utepbergenov; Urszula Derewenda; Natalya Olekhnovich; Gabriela Szukalska; Budhaditya Banerjee; Michael K Hilinski; Deborah A Lannigan; P Todd Stukenberg; Zygmunt S Derewenda
Journal:  Biochemistry       Date:  2012-08-06       Impact factor: 3.162

Review 4.  The unusual mechanism of inhibition of the p90 ribosomal S6 kinase (RSK) by flavonol rhamnosides.

Authors:  Darkhan Utepbergenov; Zygmunt S Derewenda
Journal:  Biochim Biophys Acta       Date:  2013-03-27

5.  Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation.

Authors:  Tomoko Sunami; Noel Byrne; Ronald E Diehl; Kaoru Funabashi; Dawn L Hall; Mari Ikuta; Sangita B Patel; Jennifer M Shipman; Robert F Smith; Ikuko Takahashi; Joan Zugay-Murphy; Yoshikazu Iwasawa; Kevin J Lumb; Sanjeev K Munshi; Sujata Sharma
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

6.  The crystal structures of substrate and nucleotide complexes of Enterococcus faecium aminoglycoside-2''-phosphotransferase-IIa [APH(2'')-IIa] provide insights into substrate selectivity in the APH(2'') subfamily.

Authors:  Paul G Young; Rupa Walanj; Vendula Lakshmi; Laura J Byrnes; Peter Metcalf; Edward N Baker; Sergei B Vakulenko; Clyde A Smith
Journal:  J Bacteriol       Date:  2009-05-08       Impact factor: 3.490

7.  A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.

Authors:  Yong-Yeon Cho; Ke Yao; Angelo Pugliese; Margarita L Malakhova; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

8.  Identification of domains responsible for ubiquitin-dependent degradation of dMyc by glycogen synthase kinase 3beta and casein kinase 1 kinases.

Authors:  Margherita Galletti; Sara Riccardo; Federica Parisi; Carlina Lora; Mahesh Kumar Saqcena; Leinny Rivas; Bonnie Wong; Alexis Serra; Florenci Serras; Daniela Grifoni; PierGiuseppe Pelicci; Jin Jiang; Paola Bellosta
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

9.  Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.

Authors:  Gergő Gógl; Anita Alexa; Bence Kiss; Gergely Katona; Mihály Kovács; Andrea Bodor; Attila Reményi; László Nyitray
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

10.  Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.

Authors:  Margarita Malakhova; Igor Kurinov; Kangdong Liu; Duo Zheng; Igor D'Angelo; Jung-Hyun Shim; Valerie Steinman; Ann M Bode; Zigang Dong
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.